{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:06:48Z","timestamp":1762160808712},"reference-count":41,"publisher":"Japanese Pharmacological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1254\/jphs.09299fp","type":"journal-article","created":{"date-parts":[[2010,3,19]],"date-time":"2010-03-19T06:02:42Z","timestamp":1268978562000},"page":"290-298","source":"Crossref","is-referenced-by-count":14,"title":["Effects of KRN633, an Inhibitor of Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase, on Vascular Development of Placenta and Fetus of Mid Pregnancy in Mice"],"prefix":"10.1254","volume":"112","author":[{"given":"Yoshiko","family":"Wada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomichi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Nagamitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182–1186.","DOI":"10.1056\/NEJM197111182852108"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Shibuya M. Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. BMB Rep. 2008;41: 278–286.","DOI":"10.5483\/BMBRep.2008.41.4.278"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1126\/science.2479986"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0403"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1210\/er.18.1.4"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2005.11.012"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Duda DG, Batchelor TT, Willett CG, Jain RK. VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects. Trends Mol Med. 2007;13:223–230.","DOI":"10.1016\/j.molmed.2007.04.001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ciulla TA, Rosenfeld PJ. Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration. Curr Opin Ophthalmol. 2009;20:158–165.","DOI":"10.1097\/ICU.0b013e32832d25b3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Schenone S, Bondavalli F, Botta M. Antiangiogenic agents: an update on small molecule VEGFR inhibitors. Curr Med Chem. 2007;14:2495–2516.","DOI":"10.2174\/092986707782023622"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200317189"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-5576(97)00025-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Miquerol L, Langille BL, Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development. 2000;127:3941–3946.","DOI":"10.1242\/dev.127.18.3941"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160:1405–1423.","DOI":"10.1016\/S0002-9440(10)62567-9"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021942"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Goncalves LF, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol. 2004;190:1541–1547; discussion 1547–1550.","DOI":"10.1016\/j.ajog.2004.03.043"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004;95:884–891.","DOI":"10.1161\/01.RES.0000147365.86159.f5"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1955"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Lu F, Longo M, Tamayo E, Maner W, Al-Hendy A, Anderson GD, et al. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol. 2007;196:396 e391–e397; discussion 396 e397.","DOI":"10.1016\/j.ajog.2006.12.024"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Regnault TR, Galan HL, Parker TA, Anthony RV. Placental development in normal and compromised pregnancies – a review. Placenta. 2002;23 Suppl A:S119–S129.","DOI":"10.1053\/plac.2002.0792"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Sibley CP, Turner MA, Cetin I, Ayuk P, Boyd CA, D’Souza SW, et al. Placental phenotypes of intrauterine growth. Pediatr Res. 2005;58:827–832.","DOI":"10.1203\/01.PDR.0000181381.82856.23"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Rutland CS, Mukhopadhyay M, Underwood S, Clyde N, Mayhew TM, Mitchell CA. Induction of intrauterine growth restriction by reducing placental vascular growth with the angioinhibin TNP-470. Biol Reprod. 2005;73:1164–1173.","DOI":"10.1095\/biolreprod.105.043893"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Nakamura K, Yamamoto A, Kamishohara M, Takahashi K, Taguchi E, Miura T, et al. KRN633: a selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth. Mol Cancer Ther. 2004;3:1639–1649.","DOI":"10.1158\/1535-7163.1639.3.12"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C300012200"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Kamba T, Tam BY, Hashizume H, Haskell A, Sennino B, Mancuso MR, et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol. 2006;290:H560–H576.","DOI":"10.1152\/ajpheart.00133.2005"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Krebs C, Macara LM, Leiser R, Bowman AW, Greer IA, Kingdom JC. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol. 1996;175:1534–1542.","DOI":"10.1016\/S0002-9378(96)70103-5"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest. 1997;99:2152–2164.","DOI":"10.1172\/JCI119388"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(98)80043-4"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1016\/S0012-1606(03)00449-4"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1038\/376066a0"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1038\/376062a0"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1038\/380435a0"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1038\/380439a0"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Kitamoto Y, Tokunaga H, Tomita K. Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. J Clin Invest. 1997;99: 2351–2357.","DOI":"10.1172\/JCI119416"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med. 2002;8: 702–710.","DOI":"10.1038\/nm721"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Brissova M, Shostak A, Shiota M, Wiebe PO, Poffenberger G, Kantz J, et al. Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes. 2006;55:2974–2985.","DOI":"10.2337\/db06-0690"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Inai T, Mancuso M, Hashizume H, Baffert F, Haskell A, Baluk P, et al. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol. 2004;165:35–52.","DOI":"10.1016\/S0002-9440(10)63273-7"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Baffert F, Le T, Sennino B, Thurston G, Kuo CJ, Hu-Lowe D, et al. Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol. 2006;290:H547–H559.","DOI":"10.1152\/ajpheart.00616.2005"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Hewitt DP, Mark PJ, Waddell BJ. Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat. Endocrinology. 2006;147:5568–5574.","DOI":"10.1210\/en.2006-0825"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90457-X"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Barker DJ. The fetal and infant origins of disease. Eur J Clin Invest. 1995;25:457–463.","DOI":"10.1111\/j.1365-2362.1995.tb01730.x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Baschat AA, Hecher K. Fetal growth restriction due to placental disease. Semin Perinatol. 2004;28:67–80.","DOI":"10.1053\/j.semperi.2003.10.014"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T02:29:57Z","timestamp":1685500197000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/112\/3\/112_09299FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.09299fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}